Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
Cash from Financing Activities
-€131k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
Cash from Financing Activities
-€308m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
Cash from Financing Activities
-€54.3m
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
1%
No Stocks Found

Hyloris Pharmaceuticals SA
Glance View

Market Cap
160.7m EUR
Industry
Pharmaceuticals

Hyloris Pharmaceuticals SA engages in the development and reformulating of pharmaceutical products. The company is headquartered in Liege, Liege and currently employs 14 full-time employees. The company went IPO on 2020-06-29. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.

HYL Intrinsic Value
4.38 EUR
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Hyloris Pharmaceuticals SA's Cash from Financing Activities?
Cash from Financing Activities
-131k EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's Cash from Financing Activities amounts to -131k EUR.

Back to Top